Drug Pipeline

Divarasib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
10
Active Studies
5
Recruiting
5
Phase 3
2
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT06793215
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus…
Trial sites expanded: 240 -> 251 locations
2026-05-27 NCT04929223
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of…
Trial sites expanded: 76 -> 82 locations
2026-05-23 NCT04302025
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages…
Primary endpoint(s) modified
Active Studies by Phase
Phase 3
4
Phase 2/3
1
Phase 2
2
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05862285 A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La… Cancer Recruiting
NCT06793215 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus… Non-Small Cell Lung Cancer Recruiting
NCT06497556 A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in… Non-Small Cell Lung Cancer Active, Not Recruiting
NCT07541170 A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's… Non-small Cell Lung Cancer Not Yet Recruiting
Phase 2/3
NCT03178552 A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments… Non-Small Cell Lung Cancer Active, Not Recruiting
Phase 2
NCT04302025 A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages… Non-small Cell Lung Cancer Recruiting
NCT04589845 Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… Solid Tumors Active, Not Recruiting
Phase 1/2
NCT05789082 A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single… Non-Small Cell Lung Cancer Recruiting
Phase 1
NCT04929223 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of… Metastatic Colorectal Cancer Recruiting
NCT04449874 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in… Non-Small Cell Lung Cancer Active, Not Recruiting
Sponsors Running Divarasib Trials
Disease Areas
Get alerts when Divarasib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free